These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 29338686)

  • 1. Correction to: Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults - a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing.
    Sommerauer C; Schlender L; Krause M; Weißbach S; Rieckert A; Martinez YV; Reeves D; Renom-Guiteras A; Kunnamo I; Sönnichsen A
    BMC Geriatr; 2018 Jan; 18(1):12. PubMed ID: 29338686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.
    ; Bousser MG; Bouthier J; Büller HR; Cohen AT; Crijns H; Davidson BL; Halperin J; Hankey G; Levy S; Pengo V; Prandoni P; Prins MH; Tomkowski W; Torp-Pedersen C; Wyse DG
    Lancet; 2008 Jan; 371(9609):315-21. PubMed ID: 18294998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation.
    Renda G; Zimarino M; Ricci F; Piccini JP; Ezekowitz MD; Patel MR; Cappato R; Giugliano RP; De Caterina R
    Am J Med; 2016 Oct; 129(10):1117-1123.e2. PubMed ID: 27262782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction to: Parma consensus statement on metabolic disruptors.
    Heindel JJ; Vom Saal FS; Blumberg B; Bovolin P; Calamandrei G; Ceresini G; Cohn BA; Fabbri E; Gioiosa L; Kassotis C; Legler J; La Merrill M; Rizzi L; Machtinger R; Mantovani A; Mendez MA; Montanini L; Molteni L; Nagel SC; Parmigiani S; Panzica G; Paterlini S; Pomatto V; Ruzzin J; Sartor G; Schug TT; Street ME; Suvorov A; Volpi R; Zoeller RT; Palanza P
    Environ Health; 2017 Dec; 16(1):130. PubMed ID: 29212512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic management of atrial fibrillation in the elderly.
    Edholm K; Ragle N; Rondina MT
    Med Clin North Am; 2015 Mar; 99(2):417-30. PubMed ID: 25700592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trials of new oral anticoagulants for stroke prevention in atrial fibrillation.
    Liew A; Eikelboom JW; O'Donnell M
    Curr Opin Cardiol; 2012 Jul; 27(4):331-9. PubMed ID: 22573171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Which drug should we use for stroke prevention in atrial fibrillation?
    Lau YC; Lip GY
    Curr Opin Cardiol; 2014 Jul; 29(4):293-300. PubMed ID: 25029448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Vitamins K antagonists in non-valvular atrial fibrillation thromboembolic risk prevention in Burkina Faso.
    Yameogo AR; Kologo JK; Mandi G; Kabore HP; Millogo GR; Seghda AA; Samadoulougou AK; Zabsonre P
    Pan Afr Med J; 2016; 24():108. PubMed ID: 27642447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in oral anticoagulation for atrial fibrillation.
    Singh M; Adigopula S; Patel P; Kiran K; Khosla S
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):395-407. PubMed ID: 20965952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
    Chevalier J; Delaitre O; Hammès F; de Pouvourville G
    Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulation in atrial fibrillation in the elderly: the geriatrician point of view with a focus on the direct oral anticoagulants].
    Vogel T; Geny B; Kaltenbach G; Lang PO
    Rev Med Interne; 2015 Jan; 36(1):22-30. PubMed ID: 25234463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction to: DamID profiling of dynamic Polycomb-binding sites in Drosophila imaginal disc development and tumorigenesis.
    La Fortezza M; Grigolon G; Cosolo A; Pindyurin A; Breimann L; Blum H; van Steensel B; Classen AK
    Epigenetics Chromatin; 2018 Jul; 11(1):38. PubMed ID: 29970137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction to: The Firearm Safety Among Children and Teens (FACTS) Consortium: defining the current state of the science on pediatric firearm injury prevention.
    Cunningham RM; Carter PM; Zimmerman MA
    J Behav Med; 2019 Oct; 42(5):998. PubMed ID: 31446558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
    Becattini C; Vedovati MC; Agnelli G
    Thromb Res; 2012 Mar; 129(3):392-400. PubMed ID: 22264937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction to: Detection and full genome characterization of two beta CoV viruses related to Middle East respiratory syndrome from bats in Italy.
    Moreno A; Lelli D; De Sabato L; Zaccaria G; Boni A; Sozzi E; Prosperi A; Lavazza A; Cella E; Castrucci MR; Ciccozzi M; Vaccari G
    Virol J; 2018 Jan; 15(1):10. PubMed ID: 29329554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Travels to the tropics: Deutschtum and Fedor Krause's visits to Brazil.
    Figueiredo EG; Almeida da Silva S; Jacobsen Teixeira M; Belykh E; Carotenuto A; Moreira LB; Spetzler RF; Dagi TF; Preul MC
    J Neurosurg; 2020 Jun; 132(6):1977-1984. PubMed ID: 30952119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-Analysis of Safety and Efficacy of Uninterrupted Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists for Catheter Ablation of Atrial Fibrillation.
    Elgendy AY; Mahtta D; Barakat AF; Abuzaid A; Mahmoud A; Mentias A; Mahmoud AN; Elgendy IY
    Am J Cardiol; 2017 Nov; 120(10):1830-1836. PubMed ID: 28882334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].
    Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M
    Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.